919 ANEMIA AND ITS MANAGEMENT IN PATIENTS TREATED WITH TELAPREVIR TWICE DAILY VERSUS EVERY 8 HOURS IN THE PHASE III OPTIMIZE STUDY

✍ Scribed by Zeuzem, S.; Buti, M.; Agarwal, K.; Horsmans, Y.; Sievert, W.; Janczewska, E.; Nyberg, L.; Brown, R.S.; Hezode, C.; Rizzetto, M.; Parana, R.; De Meyer, S.; De Masi, R.; Luo, D.; Van Solingen-Ristea, R.; Witek, J.

• Book ID: 122090009
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 144 KB
• Volume: 58
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(13)60921-6